CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 66 enrolled
Drug / intervention
Medical Marijuanadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03233633
NCT03233633Phase 1Completed
CompareCT.gov

Marijuana in Combination With Opioids for Pain and Symptom Control in Hospice Patients

The Connecticut Hospice Inc.·interventional·Posted Jul 28, 2017·Updated Nov 6, 2024

In Brief

A Phase 1 clinical trial evaluating Medical Marijuana for Pain. Completed, enrolled 66 participants across 1 site.

Detailed Summary

Study Objectives: Primary reduction of pain and reduction in overall opioid utilization. Secondary improvement in overall patient well being, weight stabilization with increased appetite, improved oxygen saturation, improvement or prevention of nausea and vomiting. Study Rationale: To determine optimum use and dosing of medical marijuana (CBD:THC) for pain and symptom management. Study Population: This study specifically will enroll cancer and non-cancer patients as a primary diagnosis suffering from pain and having a terminal illness (defined as having less than 6 months to live) requiring end of life care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
201820192020202120222023202420252026
First PostedJul 28, 2017
Enrollment StartMay 10, 2017
Primary CompletionAug 5, 2022
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 8.9 years ago

Interventions

Medical Marijuanadrug

oral capsule, high ratio CBD:THC